Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Intravenous Ciprofloxacin and Intravenous Ceftriaxone in the Management of Spontaneous Bacterial Peritonitis in Cirrhosis of Liver
NCT07552870Completed
- Sponsor
- Shahida Islam Medical Complex
- Start
- Jan 2026
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ciprofloxacin in spontaneous bacterial peritonitis (SBP) (2 arms), sponsored by Shahida Islam Medical Complex. Primary endpoint: Percentage of Efficacy at 1 month. Started Jan 2026; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT07552870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07552870.